- Home
- GFAI vs INAB Comparison
GFAI vs INAB Comparison
Compare GFAI & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFAI
- INAB
- Stock Information
- Founded
- GFAI 2018
- INAB 2016
- Country
- GFAI Singapore
- INAB United States
- Employees
- GFAI N/A
- INAB N/A
- Industry
- GFAI Diversified Commercial Services
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- GFAI Consumer Discretionary
- INAB Health Care
- Exchange
- GFAI Nasdaq
- INAB Nasdaq
- Market Cap
- GFAI 23.3M
- INAB 14.5M
- IPO Year
- GFAI N/A
- INAB 2021
- Fundamental
- Price
- GFAI $1.41
- INAB $2.14
- Analyst Decision
- GFAI Strong Buy
- INAB Strong Buy
- Analyst Count
- GFAI 1
- INAB 2
- Target Price
- GFAI $4.50
- INAB $108.00
- AVG Volume (30 Days)
- GFAI 626.2K
- INAB 156.7K
- Earning Date
- GFAI 04-28-2025
- INAB 08-07-2025
- Dividend Yield
- GFAI N/A
- INAB N/A
- EPS Growth
- GFAI N/A
- INAB N/A
- EPS
- GFAI N/A
- INAB N/A
- Revenue
- GFAI $36,347,373.00
- INAB N/A
- Revenue This Year
- GFAI $5.66
- INAB N/A
- Revenue Next Year
- GFAI $4.69
- INAB N/A
- P/E Ratio
- GFAI N/A
- INAB N/A
- Revenue Growth
- GFAI 0.18
- INAB N/A
- 52 Week Low
- GFAI $0.76
- INAB $2.05
- 52 Week High
- GFAI $3.88
- INAB $26.76
- Technical
- Relative Strength Index (RSI)
- GFAI 71.83
- INAB 38.00
- Support Level
- GFAI $1.17
- INAB $2.15
- Resistance Level
- GFAI $1.24
- INAB $2.25
- Average True Range (ATR)
- GFAI 0.08
- INAB 0.13
- MACD
- GFAI 0.02
- INAB 0.08
- Stochastic Oscillator
- GFAI 76.92
- INAB 30.99
About GFAI Guardforce AI Co. Limited
Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.